How I Treat Rhabdomyolysis-Induced AKI?AKIrhabdomyolysisdoi:10.2215/CJN.0000000000000372Lu, YanNeyra, Javier A.American Society of NephrologyClinical journal of the American Society of Nephrology: CJASN
Ann. Intensive Care (2019) 9:6 https://doi.org/10.1186/s13613-019-0481-3 REVIEW Open Access Weaning failure of cardiovascular origin: how to suspect, detect and treat—a review of the literature Christina Routsi1*, Ioannis Stanopoulos2, Stelios Kokkoris1, Antonios ...
87 In our practice, we prefer to use apixaban or dabigatran (which also has an antidote available) at lower doses. Case 3 A 76-year-old man with a history of heart failure resulting from coronary artery disease and valvular heart disease was admitted for dyspnea. Anemia (hemoglobin 8.3 g...
In the performance world an intermezzo is a brief dance or music show put between the sections of the longer performance. Thus it's no surprise that the new drug to treat disrupted sleep (that brief period of life between the longer waking hours, which are the main part of the show of ...
Steroid-resistant nephrotic syndrome (SRNS) is a common cause of chronic kidney disease in childhood and has a significant risk of rapid progression to end-stage renal disease. The identification of over 50 monogenic causes of SRNS has revealed dysfunction in podocyte-associated proteins in the path...
In this review, we discuss the current knowledge on the biological processes implicated in I/R injury and explore the strategies and interventions that are being proposed to either prevent I/R injury, treat its deleterious consequences, or support the reparative response of the kidney. Prospects ...
3. New agents in development for RRMM 4. How and when to treat patients with RRMM? 5. Improving outcomes and HRQoL 6. Discussion 7. Conclusions Conflict of interest statement Acknowledgements References VitaeShow full outline Cited by (36) Figures (2) Tables (1) Table 1Critical...
Decreased kidney function is associated with increased risk of cardiovascular events and mortality, and heart failure (HF) is a well-known risk factor for renal dysfunction. Acute kidney injury (AKI) in patients with HF often is attributed to prerenal factors, such as renal hypoperfusion and ...
Russell et al.2016). There is also evidence of a longitudinal shift in the immune profiles of patients, with an inflammatory phenotype seen in early disease giving way to an anti-inflammatory or immunosuppressed phenotype, indicating activation of the compensatory anti-inflammatory reflex system (Morr...
Immune checkpoint inhibitors (ICIs) are antibodies that target certain immune checkpoints (ICs), such as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed death 1 (PD-1) or its ligand (PD-L1), and have emerged as a powerful new tool for oncologists. As these immune ...